Literature DB >> 23613388

Metformin inhibits proliferation and promotes apoptosis of HER2 positive breast cancer cells by downregulating HSP90.

Tian-wen Chen1, Ya-nan Liang, Duo Feng, Lin-yu Tao, Ke Qi, Hao-yun Zhang, Hong-xian Wang, Qiu-sheng Lin, Heng Kong.   

Abstract

PURPOSE: To investigate the effects and the possible molecular mechanisms of metformin on HER2 positive breast cancer cells.
METHODS: SK-BR-3 HER2 positive breast cancer cells were treated with different concentrations of metformin. The growth inhibitory rate of the cells was calculated by MTT assay, apoptosis was detected by flow cytometry, and the expression level of heat shock protein 90 (HSP90) was performed by Western blot analysis. A control group consisted of cells treated with PBS.
RESULTS: With increased concentrations of metformin, cell growth inhibitory rates increased. The growth inhibitory rates with 0.5 mM, 2mM or 8mM metformin were significantly higher compared with the control group (p<0.05). Apoptosis in the metformin treated cells was also significantly higher compared with the control group (p=0.003). The expression level of HSP90 in the metformin group was significantly lower than that in the control group.
CONCLUSION: Metformin can inhibit the proliferation and promote apoptosis of HER2 positive breast cancer cells,which is maybe related to inhibition of HSP90.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23613388

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  8 in total

1.  Relationship between Diabetes and Diabetes Medications and Risk of Different Molecular Subtypes of Breast Cancer.

Authors:  Hongjie Chen; Linda S Cook; Mei-Tzu C Tang; Deirdre A Hill; Charles L Wiggins; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-08-08       Impact factor: 4.254

2.  Metformin effects on malignant cells and healthy PBMC; the influence of metformin on the phenotype of breast cancer cells.

Authors:  Ana Damjanović; Ivana Z Matić; Marija Ðorđić; Marina Nikolić Ðurović; Srđan Nikolić; Ksenija Roki; Zorka Milovanović; Jelena Antić-Stanković; Radan Džodić; Svetozar Damjanović; Ksenija Kanjer; Zaki Abu Rabi; Zorica Juranić
Journal:  Pathol Oncol Res       Date:  2014-10-29       Impact factor: 3.201

3.  Fibroblasts rescue oral squamous cancer cell from metformin-induced apoptosis via alleviating metabolic disbalance and inhibiting AMPK pathway.

Authors:  Zhuoyuan Zhang; Xiao Liang; Yaping Fan; Zhenjie Gao; Laurence A Bindoff; Daniela Elena Costea; Longjiang Li
Journal:  Cell Cycle       Date:  2019-04-23       Impact factor: 4.534

4.  Metformin induces apoptosis via a mitochondria-mediated pathway in human breast cancer cells in vitro.

Authors:  Zhen-Yuan Gao; Zhe Liu; Ming-Hong Bi; Jing-Jing Zhang; Zheng-Quan Han; Xiao Han; Hong-Ya Wang; Guo-Ping Sun; Hao Liu
Journal:  Exp Ther Med       Date:  2016-03-10       Impact factor: 2.447

5.  Metformin suppresses breast cancer growth via inhibition of cyclooxygenase-2.

Authors:  Bin Shi; Xinyu Hu; Huimin He; Wenzheng Fang
Journal:  Oncol Lett       Date:  2021-06-23       Impact factor: 2.967

6.  Regulation of insulin-like growth factor signaling by metformin in endometrial cancer cells.

Authors:  Ya Xie; Jing-Lu Wang; Mei Ji; Zhong-Fu Yuan; Zheng Peng; Yi Zhang; Jian-Guo Wen; Hui-Rong Shi
Journal:  Oncol Lett       Date:  2014-08-20       Impact factor: 2.967

7.  Association of diabetes and diabetes treatment with incidence of breast cancer.

Authors:  Esther García-Esquinas; Elisabeth Guinó; Gemma Castaño-Vinyals; Beatriz Pérez-Gómez; Javier Llorca; Jone M Altzibar; Rosana Peiró-Pérez; Vicente Martín; Concepción Moreno-Iribas; Adonina Tardón; Francisco Javier Caballero; Montse Puig-Vives; Marcela Guevara; Tania Fernández Villa; Dolores Salas; Pilar Amiano; Trinidad Dierssen-Sotos; Roberto Pastor-Barriuso; María Sala; Manolis Kogevinas; Nuria Aragonés; Víctor Moreno; Marina Pollán
Journal:  Acta Diabetol       Date:  2015-04-29       Impact factor: 4.280

8.  The Effect of Metformin on the Clinicopathological Features of Breast Cancer With Type 2 Diabetes.

Authors:  Weili Min; Baofeng Wang; Aining Guo; Guochao Mao; Yang Zhao; Shuqun Zhang; Rui He; Yihe Min; Yi Huang
Journal:  World J Oncol       Date:  2020-02-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.